Your browser doesn't support javascript.
loading
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.
Azzouzi, Abdel-Rahmène; Vincendeau, Sébastien; Barret, Eric; Cicco, Antony; Kleinclauss, François; van der Poel, Henk G; Stief, Christian G; Rassweiler, Jens; Salomon, Georg; Solsona, Eduardo; Alcaraz, Antonio; Tammela, Teuvo T; Rosario, Derek J; Gomez-Veiga, Francisco; Ahlgren, Göran; Benzaghou, Fawzi; Gaillac, Bertrand; Amzal, Billy; Debruyne, Frans M J; Fromont, Gaëlle; Gratzke, Christian; Emberton, Mark.
Afiliación
  • Azzouzi AR; Department of Urology, Angers University Hospital, Angers, France.
  • Vincendeau S; Department of Urology, CIC-INSERM 1414, Rennes University Hospital, Rennes, France.
  • Barret E; Department of Urology, Institut Montsouris, Université Paris Descartes, Paris, France.
  • Cicco A; Department of Urology, Centre Catalan Urologie Andrologie, Cabestany, France.
  • Kleinclauss F; Department of Urology, Besançon University Hospital, Besançon, France.
  • van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
  • Stief CG; Department of Urology, LMU-Klinikum der Universität München, Munich, Germany.
  • Rassweiler J; Department of Urology, SLK Kliniken, Heilbronn, Germany.
  • Salomon G; Martini-Clinic Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Solsona E; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Alcaraz A; Department of Urology, Hospital Clinic, Barcelona, Spain.
  • Tammela TT; Department of Urology, Tampere University Hospital and School of Medicine, Tampere, Finland.
  • Rosario DJ; Academic Department of Urology, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK.
  • Gomez-Veiga F; Department of Urology, Salamanca University Hospital GITUR-IBSAL, Salamanca, Spain; Department of Urology, University Hospital Complex, La Coruna, Spain.
  • Ahlgren G; Department of Urology, Skäne University Hospital, Malmö, Sweden.
  • Benzaghou F; Medical Department, Steba Biotech, Paris, France.
  • Gaillac B; Medical Department, Steba Biotech, Paris, France.
  • Amzal B; LA-SER Analytica, London, UK.
  • Debruyne FM; Andros Men's Health Institute, Arnhem, Netherlands.
  • Fromont G; Department of Pathology, Tours University Hospital, Tours, France.
  • Gratzke C; Department of Urology, LMU-Klinikum der Universität München, Munich, Germany.
  • Emberton M; Division of Surgery and Interventional Science, University College London, London, UK. Electronic address: m.emberton@ucl.ac.uk.
Lancet Oncol ; 18(2): 181-191, 2017 Feb.
Article en En | MEDLINE | ID: mdl-28007457
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fotoquimioterapia / Neoplasias de la Próstata / Bacterioclorofilas / Fármacos Fotosensibilizantes Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fotoquimioterapia / Neoplasias de la Próstata / Bacterioclorofilas / Fármacos Fotosensibilizantes Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Francia